Research on cancer by the biomedical engineering team at CEIT-IK4 has been recognized by organizations like the Spanish Association Against Cancer (AECC)

cancer research

Researchers from different areas of specialization collaborate on the fight against cancer through a rigorous multidisciplinary approach to research.

Engineers at Tecnun and CEIT-IK4 work in collaboration with doctors at Clínica Universidad de Navarra and biologists and pharmacists at the Center for Biomedical Engineering (CBIO) and CIMA, drawing on their shared vision and expertise to make advancements in the fight against cancer.

Oihane Mitxelena, a biomedical engineer and member of the biomedical engineering team, recently received recognition for her cancer-related research. The University College London awarded her the prize for best Master's Project, in which Mitxelena developed microbubbles that are able to deliver cancer fighting drugs to the specific area affected by a tumour.

CEIT-IK4 researchers Maite Mujika and Sergio Arana are currently collaborating with a group of researchers from CIMA, the Center for Applied Medical Research, on the SIM-CELL project, led by the University of Zaragoza. The aim of SIM-CELL is to develop a preclinical platform for studying anti-metastatic drug treatments and how cancer cells behave when exposed to different drugs.

Another project currently underway is a study on childhood osteosarcoma, led by the research group headed by Arana and Mujika at the University of Navarra's School of Pharmacy. The goal of the project is to demonstrate the effectiveness of nanomedicine as well as the possible inhibition of metastasis. This project was recognized by the Spanish Association Against the Cancer last year in the form of a grant presented to researchers by Queen Letizia.

Since the Biomedical Engineering Area came into being in 2006, CEIT-IK4 has remained on the forefront of cancer research through its ambitious and promising projects and its collaboration with organizations that share the same high level of excellence that is found in this field in the province of Gipuzkoa.

As Dr. Mujika and Dr. Arana note, “the possibilities offered by the available technological infrastructures, along with the close collaboration we enjoy with medical experts in oncology, allows us to contribute novel solutions from the world of engineering that will surely be regularly used in area hospitals in the near future to treat this terrible disease”.

Related Information